Risk factors and preventive nursing measures of acute leukaemia complicated with respiratory tract infection in children
-
摘要:
目的 对儿童急性白血病(AL)合并呼吸道感染的危险因素进行分析,通过结果提出预防护理措施,为临床治疗提供参考。 方法 回顾性分析2018年2月—2021年2月温州医科大学附属第二医院收治的140例儿童AL患者,分为呼吸道感染组(72例)和非呼吸道感染组(68例)。收集患者的相关临床资料,分析影响儿童AL合并呼吸道感染的危险因素,并提出预防性护理措施。 结果 重度贫血、白细胞计数>10×109/L或<2×109/L、血小板<20×109/L、低蛋白血症、住院时间延长、化疗方案、预防性应用抗生素是儿童白血病合并呼吸道感染的影响因素(均P<0.05);多因素logistic回归分析显示重度贫血(OR=2.440, 95% CI:1.073~5.546)、血小板<20×109/L(OR=1.972, 95% CI:1.061~3.663)、低蛋白血症(OR=2.959, 95% CI:1.115~7.853)、IA化疗方案(OR=3.799, 95% CI:1.207~11.957)是影响儿童AL合并呼吸道感染的独立危险因素。 结论 儿童AL合并呼吸道感染的危险因素包括重度贫血、血小板<20×109/L、低蛋白血症、IA化疗方案,临床需针对上述危险因素采取预防性护理措施。 Abstract:Objective To analyse the risk factors of acute leukaemia (AL) complicated with respiratory tract infection in children and to propose preventive nursing measures based on the results, thereby providing reference for clinical treatment. Methods A retrospective analysis was performed on 140 paediatric AL patients admitted to the Second Affiliated Hospital of Wenzhou Medical University from February 2018 to February 2021, who were divided into the respiratory tract infection group (72 cases) and non-respiratory tract infection group (68 cases). Relevant clinical data of the patients were collected to analyse the risk factors affecting children with AL complicated with respiratory tract infection, and the preventive nursing measures were proposed. Results Severe anaemia, white blood cell count >10×109/L or < 2×109/L, platelet < 20×109/L, hypoproteinaemia, prolonged hospital stay, chemotherapy regimen and prophylactic use of antibiotics were the influencing factors of paediatric leukaemia complicated with respiratory tract infection (all P < 0.05). Multivariate logistic regression analysis showed that severe anaemia (OR=2.440, 95% CI: 1.073-5.546), platelet < 20×109/L (OR=1.972, 95% CI: 1.061-3.663), hypoproteinaemia (OR=2.959, 95% CI: 1.115-7.853) and IA chemotherapy regimen (OR=3.799, 95% CI: 1.207-11.957) were independent risk factors for AL complicated with respiratory tract infection in children. Conclusion The risk factors of children with AL complicated with respiratory tract infection include severe anaemia, platelet < 20×109/L, hypoproteinaemia and IA chemotherapy regimen, and preventive nursing measures should be taken in accordance with the above-mentioned risk factors in clinic. -
Key words:
- Acute leukaemia /
- Respiratory tract infection /
- Risk factors
-
表 1 影响儿童AL合并呼吸道感染的单因素分析
Table 1. Univariate analysis of factors affecting respiratory infections in children with AL
组别 例数 性别[例(%)] 年龄(x±s,岁) 血红蛋白[例(%)] 白细胞计数[例(%)] 男 女 <60 g/L ≥60 g/L (2~10)×109/L >10×109/L或<2×109/L 呼吸道感染组 72 41(56.94) 31(43.06) 8.45±1.58 49(68.06) 23(31.94) 15(20.83) 57(79.17) 非呼吸道感染组 68 40(58.82) 28(41.18) 8.21±1.73 29(42.65) 39(57.35) 29(42.65) 39(57.35) 统计量 0.051a 0.858b 9.150a 7.722a P值 0.822 0.392 0.002 0.005 组别 例数 血小板计数[例(%)] 低蛋白血症[例(%)] 化疗方案[例(%)] 住院时间(x±s,d) <30×109/L ≥30×109/L 有 无 IA化疗 DA化疗 呼吸道感染组 72 59(81.94) 13(18.06) 52(72.22) 20(27.78) 39(54.17) 33(45.83) 32.26±3.84 非呼吸道感染组 68 35(51.47) 33(48.53) 27(39.71) 41(60.29) 19(27.94) 49(72.06) 28.53±3.95 统计量 14.721a 15.039a 9.912a 4.146b P值 <0.001 <0.001 0.002 <0.001 组别 例数 预防性抗生素[例(%)] 淋巴细胞计数[例(%)] 骨髓增生程度[例(%)] 是否PICC[例(%)] 是 否 >0.5×109/L ≤0.5×109/L 活跃 一般或降低 是 否 呼吸道感染组 72 29(40.28) 43(59.72) 28(38.89) 44(61.11) 51(70.83) 21(29.17) 49(68.06) 23(31.94) 非呼吸道感染组 68 40(58.82) 28(41.18) 31(45.58) 37(54.42) 45(66.18) 23(33.82) 42(61.76) 26(38.24) 统计量 4.812a 0.644a 0.352a 0.608a P值 0.028 0.422 0.553 0.435 注:IA为去甲氧柔红霉素联合阿糖胞苷;DA为柔红霉素联合阿糖胞苷;PICC为经外周静脉行中心静脉置管。a为χ2值,b为t值。 表 2 变量赋值方法
Table 2. Variable assignment methods
变量 赋值方法 血红蛋白(g/L) <60=1,≥60=2 白细胞计数(×109/L) 2~10=1,>10或<2=2 血小板计数(×109/L) <30=1,≥30=2 低蛋白血症 无=1,有=2 住院时间(d) 以实际值赋值 化疗方案 IA化疗=1,DA化疗=2 预防性使用抗生素 无=1,有=2 是否合并呼吸道感染 否=1,是=2 表 3 儿童AL合并呼吸道感染的多因素logistic回归分析
Table 3. Multivariate logistic regression analysis of children with AL complicated with respiratory infections
项目 B SE Wald χ2 P值 OR值 95% CI 重度贫血 0.892 0.419 9.982 0.002 2.440 1.073~5.546 白细胞>2及<10(×109/L) 0.436 0.286 3.192 0.074 1.546 0.883~2.709 血小板<20×109/L 0.679 0.316 7.998 0.005 1.972 1.061~3.663 低蛋白血症 1.085 0.498 13.686 < 0.001 2.959 1.115~7.853 IA化疗方案 1.335 0.585 14.979 < 0.001 3.799 1.207~11.957 住院时间 0.415 0.276 2.889 0.089 1.514 0.882~2.601 预防性使用抗生素 0.453 0.293 1.896 0.169 1.573 0.886~2.793 -
[1] 张培芬. 儿童急性淋巴细胞白血病化疗后合并肺部感染的临床特征[D]. 广州: 南方医科大学, 2018.ZHANG P F. Clinical features of pulmonary infection in children with acute lymphoblastic leukemia after chemotherapy[D]. Guangzhou: Southern Medical University, 2018. [2] 衣晓丽, 刘晓明, 刘天峰, 等. CCLG-ALL2008方案治疗303例儿童ALL诱导期感染并发症分析[J]. 中国小儿血液与肿瘤杂志, 2017, 22(6): 286-291. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXY201706003.htmYI X L, LIU X M, LIU T F, et al. Infections during induction therapy in 339 Children with Acute Lymphoblastic Leukemia treated with CCLG-2008 protocol[J]. Journal of China Pediatric Blood and Cancer, 2017, 22(6): 286-291. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXY201706003.htm [3] 李岩, 肖晓光, 林琳, 等. 急性白血病患者合并感染的菌群分布及耐药性分析[J]. 国际检验医学杂志, 2017, 38(3): 339-341. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSQ201703020.htmLI Y, XIAO X G, LIN L, et al. Analysis on bacterial flora distribution and drug resistance in patients with acute leukemia complicating infection[J]. International Journal of Laboratory Medicine, 2017, 38(3): 339-341. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSQ201703020.htm [4] 程英英, 胡萌, 杨海平. 观察儿童急性白血病化疗后肺部感染的临床特点、影像学表现及治疗效果[J]. 包头医学院学报, 2020, 36(9): 41-44. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX202009012.htmCHENG Y Y, HU M, YANG H P. The clinical features, imaging manifestations and therapeutic effects of lung infections in children with acute leukemia after chemotherapy[J]. Journal of Baotou Medical College, 2020, 36(9): 41-44. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX202009012.htm [5] 王静, 章樱. 儿童呼吸道感染的临床特征、预后及其影响因素分析[J]. 中华全科医学, 2021, 19(2): 245-247. doi: 10.16766/j.cnki.issn.1674-4152.001778WANG J, ZHANG Y. Analysis of clinical features, prognosis and influencing factors of respiratory tract infection in children[J]. Chinese Journal of General Practice, 2021, 19(2): 245-247. doi: 10.16766/j.cnki.issn.1674-4152.001778 [6] 李妍, 史爱华. 急性白血病化疗后下呼吸道感染病原菌分布及耐药性分析[J]. 临床和实验医学杂志, 2018, 17(5): 548-550. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLC201805030.htmLI Y, SHI A H. The distribution of pathogenic bacteria and drug resistance of lower respiratory tract infection after chemotherapy of acute leukemia[J]. Journal of Clinical and Experimental Medicine, 2018, 17(5): 548-550. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLC201805030.htm [7] 孙珠君, 屈蕾, 杨肖肖. 儿童急性白血病合并呼吸道感染的危险因素及预防性护理干预分析[J]. 中国肿瘤临床与康复, 2018, 25(9): 1123-1125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZK201809028.htmSUN Z J, QU L, YANG X X. Risk factors and preventive nursing intervention for acute leukemia complicated with respiratory tract infection in children[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2018, 25(9): 1123-1125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZK201809028.htm [8] 王环. 急性白血病化疗后肺部感染患者的证型及危险因素分析[D]. 广州: 广州中医药大学, 2019.WANG H. Analysis of syndrome types and risk factors of pulmonary infection in patients with acute leukemia after chemotherapy[D]. Guangzhou: Guangzhou University of Traditional Chinese Medicine, 2019. [9] 袁萍, 张睿, 陈斗佳, 等. 急性髓系白血病诱导缓解期患者下呼吸道感染的危险因素分析[J]. 中华医院感染学杂志, 2017, 27(20): 4637-4640. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201720021.htmYUAN P, ZHANG R, CHEN D J, et al. Risk factors of nosocomial lower respiratory tract infections in patients with acute myeloid leukemia during remission period[J]. Chinese Journal of Nosocomiology, 2017, 27(20): 4637-4640. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201720021.htm [10] 杨晓阳, 蔡耘, 林丽敏, 等. 儿童急性白血病化学治疗后医院感染的危险因素及病原体分析[J]. 新医学, 2018, 49(11): 798-802. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXX201811006.htmYANG X Y, CAI Y, LIN L M, et al. Risk factors and pathogen analysis of nosocomial infection in children with acute leukemia after chemotherapy[J]. Journal of New Medicine, 2018, 49(11): 798-802. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXX201811006.htm [11] 赵美淑. 老年急性髓系白血病化疗后医院感染特点及危险因素分析[D]. 昆明: 昆明医科大学, 2019.ZHAO M S. Characteristics and risk factors of nosocomial infection in elderly patients with acute myeloid leukemia after chemotherapy[D]. Kunming: Kunming Medical University, 2019. [12] 黄璟, 李静, 何志旭, 等. 急性淋巴细胞白血病患儿在诱导缓解期的营养不良状况调查[J]. 中国肿瘤临床, 2018, 45(21): 1096-1099. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL201821005.htmHUANG J, LI J, HE Z X, et al. Analysis of malnutrition status in pediatric acute lymphoblastic leukemia patients during the induced remission stage[J]. Chinese Journal of Clinical Oncology, 2018, 45(21): 1096-1099. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL201821005.htm [13] 唐秋元. 初治非M3型AML经IA方案和DA方案诱导缓解治疗的临床疗效及不良反应对比[J]. 云南医药, 2019, 40(3): 243-245. https://www.cnki.com.cn/Article/CJFDTOTAL-YNYY201903017.htmTANG Q Y. To compare the clinical efficacy and adverse reactions of IA regimen and DA regimen in induction remission treatment of newly diagnosed non-M3 AML[J]. Medicine and Pharmacy of Yunnan, 2019, 40(3): 243-245. https://www.cnki.com.cn/Article/CJFDTOTAL-YNYY201903017.htm [14] 罗姗. 剂量调整的DA与IA方案诱导化疗成人AML疗效及安全性的比较[D]. 成都: 成都医学院, 2018.LUO S. Comparison of efficacy and safety of dose-adjusted DA and IA regimen as induction chemotherapy in adult AML patients[D]. Chengdu: Chengdu Medical College, 2018. [15] 唐晶, 张荣, 李冬梅. 急性髓系白血病患者化疗后院内感染危险因素及护理措施分析[J]. 现代医学, 2020, 48(11): 1448-1451. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX202011020.htmTANG J, ZHANG R, LI D M. Analysis of risk factors and nursing measures of nosocomial infection in patients with acute myeloid leukemia after chemotherapy[J]. Modern Medical Journal, 2020, 48(11): 1448-1451. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX202011020.htm
计量
- 文章访问数: 323
- HTML全文浏览量: 116
- PDF下载量: 7
- 被引次数: 0